VMS Asset Management

Hope Medicine focuses on researching, developing, and commercializing innovative biopharmaceuticals aimed at enhancing the quality of life for patients with various prevalent diseases. The company specializes in translational medicine, utilizing insights from global research initiatives to create monoclonal antibodies, protein drugs, and other therapeutic options targeting endocrine, cardiovascular, and metabolic disorders. By addressing the needs of underserved patient populations, Hope Medicine strives to improve health outcomes and provide access to effective and affordable treatments.

CiDi focuses on the technological innovation and execution required to create practical, self-driving commercial vehicles and products. The company has obtained public road testing permits for SAE Level 4 trucks capable of exceeding 100km/h on highways. During the first two years, the company completed numerous projects for various commercial and special vehicles. CiDi, for example, has delivered unmanned and remote-controlled mining trucks to mining areas for operation, as well as operated intelligent buses on open city streets and mass-produced V2X-connected vehicles and equipment in multiple cities and regions.

Laiye is a digital workforce platform that specializes in integrating artificial intelligence to enhance organizational productivity and creativity. The company offers a comprehensive automation process platform that includes capabilities such as robotic process automation (RPA) and intelligent document processing (IDP). Laiye's intelligent dialogue robot platform is designed to simulate human tasks, enabling automated processing of emails, documents, and report generation, as well as data entry into customer relationship management systems. By leveraging these technologies, Laiye helps enterprises streamline their operations, improve efficiency, and reduce operational costs.

Slope Finance is a decentralized exchange and wallet platform built on the Solana blockchain, designed to facilitate crypto trading and management. It provides users with access to Solana Pay, decentralized finance features, and tools for visual management of non-fungible tokens. The platform offers a decentralized automated full limit order book, allowing for fast token swaps and transactions with near-zero fees. Users can create new wallets or import existing ones from Ethereum and Solana, enabling them to store and manage digital assets seamlessly. With its intuitive interface that resembles centralized exchanges, Slope Finance aims to enhance the user experience in the rapidly evolving cryptocurrency market.

SyMap Medical focuses on developing and manufacturing a proprietary catheter-based system for renal mapping and ablation, specifically aimed at treating hypertension and various other serious conditions, including heart failure, arrhythmia, and renal failure. The company's core technology platform is based on radiofrequency (RF) ablation, which is integral to its approach in renal nerve mapping and selective ablation. This innovative medical device is designed to enhance treatment options for patients suffering from these significant health issues.

Uniskin is a cosmetics brand that provides skin-care products suitable for the local area and people.

HAI ROBOTICS, founded in 2016 and based in Shenzhen, China, specializes in autonomous case-handling robotic systems for warehouse automation. The company offers a variety of intelligent solutions, including a goods-to-person system, smart in-plant logistics solutions for manufacturing, and multi-tier steel platforms for diverse applications. As a pioneer in the field, HAI ROBOTICS launched its first autonomous case-handling robot, HAIPICK, in 2015, and has since focused on research and development, securing numerous patents. The HAIPICK system significantly enhances warehouse efficiency, reportedly increasing operational productivity by three to four times and boosting storage density by 80% to 130%. HAI ROBOTICS caters to a broad range of clients, including major logistics and supply chain companies, and is committed to delivering flexible and customizable automation solutions to optimize warehouse operations.

Inmagene Biopharmaceuticals Co. Ltd. is a Shanghai-based biopharmaceutical company founded in 2019, specializing in the research and pre-clinical development of therapies for immunology-related diseases. The company focuses on creating innovative drug candidates that address unmet medical needs globally, employing a strategy known as "Borderless Innovation." Inmagene has developed a diverse pipeline, including IMG-020, a protein drug designed to target IL-17A, which utilizes a combination of Affibody's protein therapeutics platform and Albumod technology to enhance potency and extend half-life. In addition to IMG-020, the company boasts several clinical-stage assets and multiple preclinical candidates aimed at improving pharmacokinetic and pharmacodynamic properties, safety profiles, and dosing convenience for patients. With additional offices in Hangzhou and Beijing, Inmagene is dedicated to advancing drug development through cutting-edge technology and a commitment to global collaboration in the fight against immunological diseases.

CiDi focuses on the technological innovation and execution required to create practical, self-driving commercial vehicles and products. The company has obtained public road testing permits for SAE Level 4 trucks capable of exceeding 100km/h on highways. During the first two years, the company completed numerous projects for various commercial and special vehicles. CiDi, for example, has delivered unmanned and remote-controlled mining trucks to mining areas for operation, as well as operated intelligent buses on open city streets and mass-produced V2X-connected vehicles and equipment in multiple cities and regions.

BlissBio is a biopharmaceutical company dedicated to the development of innovative therapies for cancer treatment. The company specializes in tumor targeting and immunotherapy, focusing on the creation of antibody-drug conjugates and site-specific conjugate technologies. With a robust pipeline of products, BlissBio possesses independent intellectual property rights that support the advancement and commercialization of its anti-tumor therapies, aiming to provide effective solutions for patients battling cancer.

Chime Biologics Limited is a Contract Development and Manufacturing Organization (CDMO) based in Wuhan, China, established in 2013. The company specializes in providing a comprehensive range of biopharmaceutical development and manufacturing services, including drug substance and drug product manufacturing, cell line development, and protein science characterization. Chime Biologics also offers technical transfer, regulatory support, and project management services to meet the needs of the biopharmaceutical industry. The organization supports clients through all stages of development, from early drug development to late-stage clinical trials and commercial production, ensuring compliance with cGMP standards. By delivering customer-centric and cost-effective solutions, Chime Biologics aims to enhance access to affordable medicines and improve patient care.

DiDi Freight is a freight service platform that focuses on intra-city shipping and moving solutions. The company offers a variety of vehicles to meet diverse transportation needs, ensuring each delivery is fully insured and drivers are rigorously screened. DiDi Freight aims to provide transparent pricing and reliable services to enhance the shipping experience for customers.

Windtree Therapeutics is a biotechnology company focused on developing innovative therapies for acute pulmonary and cardiovascular diseases. The company's lead development programs include istaroxime, currently in Phase 2b clinical trials for treating acute decompensated heart failure and early cardiogenic shock; AEROSURF, an aerosolized KL4 surfactant in Phase 2b trials for respiratory distress syndrome (RDS) in premature infants; lyophilized KL4 surfactant for lung injury from COVID-19; and rostafuroxin, in Phase 2b trials for genetically associated hypertension. Windtree's proprietary technology platform features a synthetic, peptide-containing surfactant (KL4 surfactant) similar to natural pulmonary surfactant, along with novel drug-delivery technologies for noninvasive administration. The company was formerly known as Discovery Laboratories and is headquartered in Warrington, Pennsylvania.

I-Mab Biopharma (Shanghai) Co., Ltd. is a clinical-stage biopharmaceutical company based in Shanghai, China, with additional offices in Beijing and Rockville, Maryland. Founded in 2016, the company focuses on the discovery, development, and commercialization of innovative biologics aimed at addressing significant unmet medical needs, particularly in the fields of immuno-oncology and immuno-inflammation. I-Mab's diverse drug pipeline targets various therapeutic areas, including multiple myeloma, autoimmune diseases, pediatric growth hormone deficiency, and several cancer indications such as head and neck cancer. Key candidates in its portfolio include Uliledlimab, an antibody for solid tumors, along with Ragistomig and Givastomig, highlighting the company's commitment to developing transformative therapies for patients.

Dingdong Maicai is a community-based online retail platform in China that specializes in fresh produce and other daily necessities. Founded in 2014 and headquartered in Shanghai, the company leverages technology to enhance its operations, allowing for direct procurement at the point of origin and efficient pre-warehouse distribution. It aims to deliver products to customers' homes in 29 minutes or less, significantly improving the fresh food consumption experience. The service is available in major cities, including Shanghai, Beijing, Shenzhen, Hangzhou, and Suzhou. Dingdong Maicai operates through its mobile application and mini-programs, generating revenue from the sale of fresh groceries and membership services, positioning itself as one of the fastest-growing on-demand e-commerce companies in China.

Bangsun Technology, based in Hangzhou, China, specializes in developing online payment security software tailored for domestic internet trading companies and financial institutions. Founded in 2010, the company offers a range of solutions, including banking and tripartite payment solutions, as well as services for bank cards, credit cards, and securities. Its product lineup features real-time transaction anti-fraud systems, Internet credit services, data analytics through machine learning, device fingerprinting, and anti-money laundering solutions. Additionally, Bangsun Technology focuses on providing comprehensive risk management services, including application anti-fraud measures and robot defense, to enhance the security of financial transactions.

New Horizon Health is a biotechnology company based in Hangzhou, China, with an additional office in Beijing, specializing in the development of innovative technologies for early cancer detection and screening. Founded in 2015, the company primarily focuses on gastrointestinal cancers, offering products such as the ColoClear and Pupu Tube, which utilize fecal gene analysis (FIT-DNA) technology for colorectal cancer screening. These products enable users to conduct in-home tests, allowing for the early detection of colon cancer and precancerous lesions that may not be identified through traditional blood tests. New Horizon Health aims to reduce cancer morbidity and mortality rates by promoting accessible and efficient health services, leveraging big data and artificial intelligence in its screening technologies. The company's commitment to early cancer screening reflects its mission to enhance public health by facilitating widespread access to vital diagnostic tools.

Shanghai Zhangmen Education Technology Co., Ltd. operates Zhangmen, an online tutoring platform that offers personalized tutoring courses for primary and middle school students aged eight to 18. Founded in 2014 and based in China, Zhangmen allows students to connect with highly qualified teachers who have graduated from prestigious universities such as Tsinghua, Peking University, and Fudan University. The platform provides a range of educational services, including one-on-one tutoring and comprehensive online education classes. Through its online and mobile applications, Zhangmen aims to enhance the learning experience by offering tailored educational support to meet the individual needs of each student.

Crossbar Inc. specializes in developing and licensing resistive RAM (ReRAM) technology, which offers innovative non-volatile memory solutions for various applications. Founded in 2008 and headquartered in Santa Clara, California, the company’s technology enables the storage of up to one terabyte of data on a chip the size of a postage stamp, providing high performance with low power consumption. Crossbar's ReRAM is designed for use in consumer electronics, mobile devices, enterprise storage systems, and IoT applications such as smart meters and industrial sensors. By allowing for integrated compute and storage subsystems, Crossbar's memory solutions aim to redefine the traditional constraints of flash and DRAM technologies, enhancing both edge and cloud computing capabilities. The company has garnered support from top-tier investors and boasts a team of experts dedicated to advancing memory technology.

Profusa, Inc. is a digital health technology company based in Emeryville, California, specializing in the development of tissue-integrated sensors and biosensors aimed at enhancing diabetes management and chronic disease care. Founded in 2009, Profusa focuses on creating biointegrated sensors that allow individuals to monitor their unique body chemistry in real time, thereby transforming personal health management. The company's technology is designed to be user-friendly and cost-effective, providing actionable, clinical-grade data to improve health outcomes. Profusa also develops software that offers biofeedback for chronic disease management and promotes healthy living. Its flagship product, Lumee Oxygen, represents a significant advancement in continuous health monitoring within the European market.

Chemclin Biotech is a Chinese technical service provider specializing in in-vitro diagnostic instruments and auxiliary reagents for clinical diagnosis. The company develops, produces, and sells clinical immunochemiluminescence diagnostic testing reagents and instruments. Its services encompass a range of clinical inspection instruments, including chemiluminescence and biochemical reagents, as well as technical support, management, and certification. Additionally, Chemclin operates independent medical laboratories and is focused on introducing innovative diagnostic products and services to the Chinese market.

TalkingData is a Beijing-based company established in 2011, specializing in advanced data analytics for the Chinese mobile internet market. It offers a suite of big data products, including scalable data mining, deep data analytics, industry benchmarking reports, and market insights. With nearly 1.5 billion devices covered, TalkingData serves 80% of China's top app developers, helping them track metrics, analyze user data, and optimize monetization strategies. The company collaborates closely with major distribution channels and ad networks, and is expanding into cross-border cooperation with financial industries.

Renrui Human Resources Technology Holdings Limited is a prominent provider of human resource solutions in China, founded in 2010 and headquartered in Chengdu. The company operates through three primary segments: Flexible Staffing, Professional Recruitment, and Other HR Solutions. Renrui specializes in comprehensive flexible staffing, offering services such as talent outsourcing, senior talent management, and various recruitment services that include membership, negotiation, onboarding, and on-site recruitment. Additionally, the company provides business process outsourcing services encompassing performance management, operations management, training management, information security, and scheduling management. With a focus on integrating digital technology into its offerings, Renrui also delivers digital operations and customer services, positioning itself as a key player in the evolving HR landscape in China.

Eden Biologics, formerly known as JHL Biotech, is a biopharmaceutical company that specializes in the development of biosimilars and offers contract development and manufacturing services to various clients and partners. The company focuses on producing a diverse range of complex dosage forms, including oral solid, liquid, and semi-solid products, as well as macromolecule biologics. By leveraging its expertise in both global and regional regulatory affairs, Eden Biologics aims to make biopharmaceuticals more affordable and accessible to patients worldwide. Through its comprehensive services, the company supports the entire process from cell line development to commercial manufacturing, enhancing the efficiency and effectiveness of biopharmaceutical development for its partners.

Youdao, Inc. is an internet technology company based in Hangzhou, China, dedicated to providing online services focused on content, community, communication, and commerce. Founded in 2006, the company specializes in developing learning content, applications, and solutions tailored for a diverse range of users, including preschoolers, K-12 students, college students, and adult learners. Its offerings include the Youdao Dictionary, Youdao Cloudnote, and various online dictionary and translation tools. The company also markets smart devices such as the Youdao Smart Pen and Youdao Pocket Translator. Youdao's primary revenue source comes from its Learning services segment, which encompasses online courses like Youdao Premium Courses and NetEase Cloud Classroom. Additionally, the company provides online marketing services and technical support, operating as a subsidiary of NetEase, Inc.

Pony.ai, Inc. is a technology company specializing in autonomous driving solutions and artificial intelligence software for automated vehicle manufacturing. Founded in 2016 and headquartered in Fremont, California, with additional offices in San Francisco and China, Pony.ai develops systems that utilize machine learning to navigate vehicles across diverse driving conditions. The company's technology focuses on accurately perceiving the vehicle's environment and predicting driver actions to enhance safety and functionality. In addition to its core development efforts, Pony.ai also operates a public-facing Robotaxi service, showcasing its advancements in autonomous mobility. Through collaborations with automotive manufacturers, Pony.ai aims to integrate its innovative technology into commercial vehicles, significantly contributing to the evolution of transportation.

Meicai is an online platform that connects farmers directly with restaurants and businesses, facilitating the sale of agricultural products. By eliminating intermediaries, Meicai allows customers to order fresh produce directly from farms, thereby streamlining the supply chain. The company aims to transform agriculture and improve the livelihoods of farmers by leveraging the Internet to create a more efficient marketplace for fresh food. Through its innovative approach, Meicai seeks to enhance the accessibility of high-quality agricultural products while supporting rural economies.

Keyssa, Inc., established in 2009 and headquartered in Campbell, California, specializes in developing and manufacturing contactless connectors and wireless semiconductors. Utilizing millimeter-wave technology, the company's flagship product, Kiss Connectivity, enables secure, instantaneous, and high-speed data transfer between devices in close proximity. This tiny, solid-state system eliminates the need for traditional metal connectors, cables, and wireless networks, offering a protocol-agnostic, EHF transmission solution. Keyssa's products cater to a wide range of applications, including mobile phones, displays, automotive, robotic surgery, factory automation, and data centers. The company's offerings, such as the KSS104U, streamline production line testing, significantly reducing overall test time. Keyssa operates additional offices in Tigard, Oregon; Shenzhen, China; Seoul, South Korea; and Taipei, Taiwan.

Gamida Cell is a clinical-stage biopharmaceutical company focused on developing innovative cell therapies for patients with blood cancers and serious hematologic diseases. The company's lead product candidate, omidubicel, is an advanced therapy utilizing nicotinamide-expanded hematopoietic stem cells, currently undergoing Phase 3 trials for patients with high-risk hematologic malignancies and a Phase 1/2 trial for severe aplastic anemia. Additionally, Gamida Cell is advancing GDA-201, a natural killer cell-based immunotherapy that is in Phase 1/2 studies for the treatment of relapsed or refractory non-Hodgkin lymphoma and multiple myeloma. Founded in 1998 and headquartered in Jerusalem, Israel, the company employs a proprietary expansion platform that enhances the properties of nicotinamide to optimize allogeneic cell sources, including umbilical cord blood-derived cells.

Souche, founded by Yao Junhong in December 2012, is a prominent automotive new retail platform in China. The company has attracted significant investments, raising over $1.2 billion by August 2018 from notable organizations such as Alibaba Group and Ant Financial Services Group. Recognized in the 2017 New Global Unicorns Ranking by PitchBook, Souche aims to be a central intelligence hub for the automotive industry. Over the years, it has developed an integrated automotive retail ecosystem that includes various businesses. These encompass Tangeche, an automotive financial leasing platform; Chehang168, a B2B industrial chain service platform; Cheyipai, an online used-car trading platform; and TIHD, a car-sharing service. Additionally, Souche offers SaaS products for used-car dealers through Dafengche and operates a new-car dealership network called Maicheguanjia. The company also provides ERP systems for dealership groups and integrated supply chain logistics services. Souche is often referred to as "the Alibaba of the Chinese automotive industry."

iQIYI, Inc. is a prominent online entertainment platform in China, offering a wide range of services including internet video streaming, online gaming, live broadcasting, online literature, and e-commerce. Established in 2009 and headquartered in Beijing, the company operates under the iQIYI brand and has developed a comprehensive library of licensed and self-produced content across various genres such as movies, TV dramas, and animations. iQIYI generates revenue primarily through subscription services, boasting around 100 million paying subscribers and 500 million monthly active users. Additionally, the platform monetizes user-generated content through advertising, while also engaging in e-commerce via the iQIYI Mall, which specializes in entertainment-related merchandise. The company has diversified its offerings to include a live broadcasting service and a social media platform focused on entertainment. iQIYI faces competition from other streaming services such as Tencent Video and Alibaba's Youku, positioning itself as a leader in the rapidly evolving digital media landscape in China.

NextVR, Inc. is a company specializing in the development and delivery of advanced video capture technology for virtual reality experiences. Founded in 2009 and headquartered in Laguna Beach, California, NextVR has created a platform that transmits live and on-demand virtual reality content in high-definition quality, enabling immersive experiences for sports events, concerts, and cinematic productions. The company holds over 26 patents related to the capture, compression, transmission, and display of virtual reality content, positioning it as a leader in the field. With strategic partnerships with major technology firms, NextVR aims to make virtual reality a mainstream medium for entertainment by ensuring that its content can be streamed effectively over standard home and mobile Internet connections. As a subsidiary of Apple Inc., NextVR continues to innovate in the realm of immersive media, enhancing access and engagement for fans around the world.

Post-Quantum is a cybersecurity company established to address the rising threat of quantum cryptanalysis. It specializes in developing systems and products aimed at safeguarding valuable data and workflows. The company offers biometric authentication solutions and a secure encrypted communications platform for both mobile and desktop devices, ensuring data confidentiality, authenticity, and access control. Additionally, Post-Quantum has expanded its focus to include Identity and Access Management (IAM) and blockchain-enabled enterprise software as a service (SaaS), providing clients with comprehensive tools to operate safely and securely in an increasingly digital landscape.

Pharmaron Beijing Co Ltd is a research and development service provider in the life sciences sector, specializing in a comprehensive range of services for drug discovery, preclinical, and clinical development. The company supports various therapeutic modalities, including small molecules, biologics, and cell and gene therapies. Pharmaron's offerings encompass laboratory chemistry, biosciences, drug metabolism and pharmacokinetics (DMPK), pharmacology, drug safety assessments, and clinical development services. Its operations are divided into several segments, with laboratory services generating the highest revenue. By providing these essential services, Pharmaron plays a crucial role in advancing the drug development process for its clients.

KingMed Diagnostics, founded in 1994, is the largest independent clinical laboratory in China, specializing in outsourced medical examination and pathology diagnosis services. The company offers a wide range of testing solutions, including mass spectrometry, immunology testing, biochemical luminescence testing, genetic testing, and various forms of pathology diagnosis. As of 2023, KingMed operates 49 centralized laboratories and provides over 4,000 different test items, with more than 90% of its revenue derived from clinical diagnostics. Additionally, KingMed has been enhancing its cold chain logistics to ensure the integrity of its testing processes. Its extensive service network covers densely populated regions across China, positioning the company as a key player in the healthcare sector.

UCloud Information Technology provides IaaS (base cloud computing), independent research and development, computational resource, storage resource, network resource, and other basic IT infrastructure services. It offers UCloud Physical Host that provides physical servers, UCloud Host, a UCloud-based mature cloud computing technology, UCloud Load Balancer, a load balancing service that offers automatic allocation of application data among multiple cloud hosts, UCloud Network, a UCloud network service that manages network resources, and UCloud Extended Hybrid Cloud that offers a hybrid deployment service of cloud platforms and server hosting. UCloud Information Technology also provides UCloud Disk that provides permanent hard disk storage space for cloud hosting, UCloud DataBase, a data base service based on mature cloud computing technology, UCloud Memory Storage, a key-value memory database, UCloud Content Delivery Network services, Object Storage that provides unstructured file storage services for Internet applications, UCloud Distributed Data Processing solutions, Cloud Security that provides testing services, and scheduling interface solutions for cloud computing resources. It serves video, O2O and E-Commerce, Internet finance, PaaS/SaaS, game, mobile SNS, online education, and digital marketing sectors. Ji Xinhua, Hua Kun, and Mo Xianfeng founded UCloud Information Technology in 2011. Its headquarters is in Shanghai in China.

FinVolution Group, formerly known as PPDai, is an online platform for peer-to-peer small unsecured loans in China. It builds a safe, high-performance, honest network platform with creative technology and ideals. FinVolution Group standardizes personal behaviors of debit and credit and brings returns to both lenders and borrowers. FinVolution was founded in August 2007 by founders from well-known companies.

Mediheal is a beauty brand that offers everyday sheet masks. The company approaches beauty scientifically, collaborating with leading dermatologists, scientists, and aestheticians to develop incredibly powerful all-in-one skin solutions. By redefining sheet masks as a flexible, expert, and cutting-edge treatment option, Mediheal has revolutionized the industry.